Correction to: ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies

Amit Kumar; Bindu Rani; Rajni Sharma; Gurjeet Kaur; Rishikesh Prasad; Ajay Bahl; Madhu Khullar

doi:10.1007/s11010-018-3482-x

Correction to: ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies

Mol Cell Biochem. 2019 Jan;450(1-2):209-210. doi: 10.1007/s11010-018-3482-x.

Authors

Amit Kumar¹, Bindu Rani¹, Rajni Sharma², Gurjeet Kaur³, Rishikesh Prasad¹, Ajay Bahl⁴, Madhu Khullar⁵

Affiliations

¹ Department of Experimental Medicine and Biotechnology, PGIMER, Lab No 2009, Research Block B, Chandigarh, 160012, India.
² Department of Otolaryngology, PGIMER, Chandigarh, India.
³ Department of Endocrinology, PGIMER, Chandigarh, India.
⁴ Department of Cardiology, PGIMER, Chandigarh, India.
⁵ Department of Experimental Medicine and Biotechnology, PGIMER, Lab No 2009, Research Block B, Chandigarh, 160012, India. madhu.khullar@gmail.com.

PMID: 30488312
DOI: 10.1007/s11010-018-3482-x

Abstract

In the original publication of the article, the location and rs number of TNNI3K mouse SNP (3784 C>T) (rs49812611) has been mentioned inadvertently in place of its human homologue. The correct information for human SNP is rs760769780 located at position 74436534, resulting in (G>A) change in human TNNI3K gene.

Publication types

Published Erratum